Hjem › Amyloidose
Amyloidose kliniske forsøg rekrutterer i USA
29 studier for Amyloidose rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Boston, MA11 studier
- New York City, NY10 studier
- Rochester, MN10 studier
- Dallas, TX9 studier
- Philadelphia, PA7 studier
- Baltimore, MD6 studier
- Houston, TX6 studier
- Portland, OR6 studier
- Durham, NC6 studier
- St. Louis, MO6 studier
- Cleveland, OH5 studier
- Chicago, IL5 studier
- Washington, DC5 studier
- San Diego, CA5 studier
- Nashville, TN5 studier
- Richmond, VA4 studier
- Los Angeles, CA4 studier
- Jacksonville, FL4 studier
- Detroit, MI4 studier
- Charlotte, NC4 studier
- Seattle, WA4 studier
- San Francisco, CA4 studier
- Columbus, OH3 studier
- Atlanta, GA3 studier
- New Haven, CT3 studier
- Mountain View, CA3 studier
- Arlington, VA3 studier
- Kansas City, MO3 studier
- Charleston, SC3 studier
- Indianapolis, IN3 studier
- Edison, NJ3 studier
- Kansas City, KS3 studier
- Aurora, CO3 studier
- Miami, FL3 studier
- Salt Lake City, UT3 studier
- Austin, TX3 studier
Efter delstat
- Arizona3 studier
- Californien8 studier
- Colorado5 studier
- Connecticut4 studier
- District of Columbia4 studier
- Florida8 studier
- Georgia3 studier
- Illinois5 studier
- Indiana3 studier
- Kansas3 studier
- Maryland7 studier
- Massachusetts11 studier
- Michigan5 studier
- Minnesota10 studier
- Missouri7 studier
- New Jersey3 studier
- New York10 studier
- North Carolina10 studier
- Ohio6 studier
- Oregon6 studier
- Pennsylvania7 studier
- South Carolina4 studier
- Tennessee7 studier
- Texas11 studier
- Utah3 studier
- Virginia4 studier
- Washington4 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07285044A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 16. sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 15. sep. 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07358078Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
RekruttererObservationsstudie
Alle aldre · Kvinder · Opdateret 8. sep. 2026 · NCT05040373ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 8. sep. 2026 · NCT04561518Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT05577819Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
RekruttererObservationsstudie
Alder 30 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 29. jul. 2026 · NCT07695701A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT05951816[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 21. jul. 2026 · NCT07560306A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. jul. 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT07081646Dietary Reporting In The Amyloidoses
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 26. jun. 2026 · NCT05738005Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 19. maj 2026 · NCT06974877A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
RekruttererFase 2
Alder 40 til 90 · Alle køn · Opdateret 13. apr. 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RekruttererFase 3
Alder 18 til 90 · Alle køn · Opdateret 27. mar. 2026 · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
RekruttererObservationsstudie
Alder 30 til 80 · Alle køn · Opdateret 7. jan. 2026 · NCT07196839Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. dec. 2025 · NCT04991103A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
RekruttererObservationsstudie
Alder 20 og opefter · Alle køn · Opdateret 26. dec. 2025 · NCT07216469Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.